# The Efficacy and Safety of Colchicine Combined With Conventional Therapy in Multiple Myeloma Patients

> **NCT05802992** · PHASE3 · UNKNOWN · sponsor: **Affiliated Hospital of Nantong University** · enrollment: 30 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Colchicine
- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT05802992
- **Lead sponsor:** Affiliated Hospital of Nantong University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-30
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05802992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05802992, "The Efficacy and Safety of Colchicine Combined With Conventional Therapy in Multiple Myeloma Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05802992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*